HPR53 How Does the Inclusion of New Drugs in National Reimbursement Drug List Influence Health Outcomes and Financial Burden for Multiple Sclerosis Patients
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1122
https://www.valueinhealthjournal.com/article/S1098-3015(24)01237-3/fulltext
Title :
HPR53 How Does the Inclusion of New Drugs in National Reimbursement Drug List Influence Health Outcomes and Financial Burden for Multiple Sclerosis Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01237-3&doi=10.1016/j.jval.2024.03.1122
First page :
Section Title :
Open access? :
No
Section Order :
10537